Home › Funds › DDFG, Inc › ARWR

DDFG, Inc position in ARWR

ARROWHEAD PHARMACEUTICALS IN · Health Care

DDFG, Inc reported holding 10,728 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$702K, representing 0.14% of its reported portfolio and ranking #48 among its reported holdings. DDFG, Inc has disclosed ARWR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)10.73K sh
Reported value held$702.15K
Portfolio Weight0.14%
First reportedQ3 2023
Last changeHold
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How DDFG, Inc's ARWR position evolved

DDFG, Inc first disclosed a stake in ARWR in Q3 2023 at 14,728 shares (US$396K). The position peaked in Q4 2025 at 14,728 shares, worth US$978K. Across 13 filings, DDFG, Inc increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 10,728 shares valued at US$702K. Notable position changes include a 27% trim in Q1 2026 (shares rose 30% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 14.73K $395.74K New
Q4 2023 14.73K $450.68K Hold
Q1 2024 14.73K $421.22K Hold
Q2 2024 14.73K $382.78K Hold
Q3 2024 14.73K $285.28K Hold
Q4 2024 14.73K $276.89K Hold
Q1 2025 14.73K $187.63K Hold
Q2 2025 14.73K $232.70K Hold
Q3 2025 14.73K $507.97K Hold
Q4 2025 14.73K $977.79K Hold
Q1 2026 10.73K $672.65K Reduce
Q2 2026 10.73K $874.44K Hold
Q3 2026 10.73K $702.15K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARWR and 13F data

ARWR (ARROWHEAD PHARMACEUTICALS IN) is a Health Care company. 53 other funds we track also report a position in ARWR — the largest reported positions include Avoro Capital Advisors LLC (US$925.6M), FRED ALGER MANAGEMENT, LLC (US$269.1M), BAKER BROS. ADVISORS LP (US$162.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARWR

All ARWR fund holders →

FAQ

How long has DDFG, Inc held ARWR?

DDFG, Inc has disclosed ARWR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DDFG, Inc's current position in ARWR?

As of Q3 2026, DDFG, Inc holds 10.73K shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), valued at $702.15K, representing 0.14% of its reported portfolio and ranking #48.

Has DDFG, Inc been buying or selling ARWR?

In the latest 13F filing (Q3 2026), DDFG, Inc held unchanged its position in ARWR. The position peaked in Q4 2025 at 14.73K shares.

Which other funds hold ARWR?

Other major institutional holders of ARWR include Avoro Capital Advisors LLC, FRED ALGER MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.